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Abstract 
Background: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bio-
process applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering 
the production of advanced biopharmaceuticals, a major hindrance lies in the yeast endoplasmic reticulum (ER), as it 
is not equipped for efficient and large scale folding of complex proteins, such as human antibodies.
Results: Following the example of professional secretory cells, we show that inducing an ER expansion in yeast by 
deleting the lipid-regulator gene OPI1 can improve the secretion capacity of full-length antibodies up to fourfold. 
Based on wild-type and ER-enlarged yeast strains, we conducted a screening of a folding factor overexpression library 
to identify proteins and their expression levels that enhance the secretion of antibodies. Out of six genes tested, addi-
tion of the peptidyl-prolyl isomerase CPR5 provided the most beneficial effect on specific product yield while PDI1, 
ERO1, KAR2, LHS1 and SIL1 had a mild or even negative effect to antibody secretion efficiency. Combining genes for ER 
enhancement did not induce any significant additional effect compared to addition of just one element. By combin-
ing the Δopi1 strain, with the enlarged ER, with CPR5 overexpression, we were able to boost the specific antibody 
product yield by a factor of 10 relative to the non-engineered strain.
Conclusions: Engineering protein folding in vivo is a major task for biopharmaceuticals production in yeast and 
needs to be optimized at several levels. By rational strain design and high-throughput screening applications we were 
able to increase the specific secreted antibody yields of S. cerevisiae up to 10-fold, providing a promising strain for 
further process optimization and platform development for antibody production.
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Background
The yeast Saccharomyces cerevisiae has proved its value 
in industrial applications, such as small chemicals and 
biofuel production, and is an excellent choice for new 
biotechnological processes due to the wide range of 
techniques to manipulate and cultivate the organism 
efficiently [1]. S. cerevisiae is also a popular choice for 
production of recombinant proteins and is currently 
the chosen production host for one-fifth of approved 
biopharmaceuticals on the market [2]. One of the main 
limitations of producing recombinant pharmaceuticals in 
yeast is the different N-glycan pattern compared to mam-
malian expression platforms [2]. However, producing 
correctly folded and glycosylated proteins for therapeutic 
applications in S. cerevisiae is about to become possible 
with the advancements of glycoengineered strains [3, 4]. 
With further optimization of the host and the production 
process, the yeast has great potential to become a viable 
platform to produce competitive yields of complex, func-
tional mammalian target proteins, such as antibodies.
The yeast endoplasmic reticulum (ER) is limited in 
its recombinant protein folding capacity, and is thus an 
important target for cell engineering to improve product 
yields [5, 6]. Producing recombinant proteins in yeast 
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often leads to accumulation of folding intermediates in 
the ER and consequently to induction of the unfolded 
protein response (UPR) [7]. The UPR is a transcriptional 
program for concomitant upregulation of over 300 genes, 
including the upregulation of basal expression levels of 
constitutively expressed quality control components in 
the ER, which include folding factors, chaperones and the 
ER associated degradation (ERAD) machinery [8–10]. 
Inactivation of the UPR has shown to be detrimental 
for heterologous protein production [11, 12]. Although 
the UPR response is shown to be specific to the source 
of stress [13], heterologous protein yields could ben-
efit most from a protein specific, fine-tuned expression 
of necessary helper proteins. One of the effects of UPR 
activation is also the Ino2/4 dependent induction of lipid 
biosynthesis genes, which play a key role in phospholipid 
biosynthesis required for membranes [14]. Although 
UPR leads to ER expansion, in yeast it has been shown 
that increasing ER size alone is sufficient to alleviate con-
formational stress independently from chaperone levels 
and UPR-induction [15]. Importance of ER size in effec-
tive protein secretion can also be noted from professional 
secretory cells, such as plasma cells and thyrocytes, that 
are characterized by an expanded ER that occupies most 
of the cytoplasmic space [16–19]. Although the devel-
opment of secretory cells employs some of the same 
molecular routes as the UPR and has similar effects on 
gene expression, the onset of protein production is pre-
ceded by ER expansion [20]. Thus increasing the size of 
ER seems like a sensible strategy to preempt the negative 
effects of protein overexpression stress and the concomi-
tant induction of UPR.
The limited folding rate in the ER of S. cerevisiae 
becomes a critical factor when producing large and com-
plex proteins, such as human antibodies. In their native 
production environment, plasma cells, antibodies employ 
several classes of folding factors in their maturing pro-
cess [21]. Molecular chaperones, such as BiP and its co-
chaperones, and folding enzymes, like protein disulfide 
isomerases (PDIs) and peptidyl-prolyl-isomerases (PPI-
ase), all interact in a sequential manner with the fold-
ing light and heavy chain polypeptides to produce the 
secreted, mature heterotetrameric antibody [21, 22]. 
Although the yeast ER contains folding factors from all 
these classes, it is questionable whether the levels and 
stoichiometry of the proteins are adequate for efficient 
IgG-assembly. Different folding assistants co-operate 
with each other and form an extensive interaction net-
work, possibly even a multiprotein complex [23–25]. 
Addition of just Pdi1p and/or Kar2p to enhance folding 
has been a popular approach [6, 26–28], but to obtain 
predictable effects the stoichiometry between the differ-
ent folding factors should be considered. Achieving the 
correct balance of folding factor expression is a laborious 
task and high-throughput techniques need to be imple-
mented to strain development in order to gain improve-
ments in protein production.
In this study, we demonstrate how yeast protein secre-
tion can be enhanced by increasing the ER space through 
deletion of the OPI1-gene. By using this strain along with 
the wild-type, we conducted a comprehensive screening 
of six yeast folding factors under control of up to five dif-
ferent promoters to identify elements and expression lev-
els that were beneficial for IgG secretion. Overexpression 
was combined with the expanded ER to produce a strain 
with high secretion levels. Our focus was on modifying 
the ER environment, and we discuss how the different 
modifications might affect heterologous protein produc-
tion in yeast.
Results and discussion
Increasing the size of yeast ER increases IgG secretion 
levels by more than fourfold
The S. cerevisiae gene OPI1 is involved in regulation 
of lipid-metabolism, and its main target is the Ino2p/
Ino4p-complex. Ino2p and Ino4p are transcription fac-
tors that work as a heterodimer to induce the transcrip-
tion of many phospholipid synthesis enzymes [29, 30]. 
The protein product of OPI1 functions as a repressor 
for the Ino2p/Ino4p-complex as Opi1p binds to Ino2p 
and inhibits the formation of the active heterodimer 
in lipid abundant conditions [31]. Removal of Opi1p by 
gene knock-out resulted in a constitutively active Ino2p/
Ino4p-complex, which upregulated the de novo synthesis 
of lipids [15, 29, 30]. The Ino2p/Ino4p-complex has a key 
role in ER size control, and removing its repressor Opi1p 
causes the yeast ER to expand by approximately 1.5-fold 
compared to the wild-type yeast ER [15].
Increase in ER size is a characteristic feature of profes-
sional secretory cell development [32, 33] and has been 
stated to reduce ER stress in S. cerevisiae [15], thus we 
decided to study whether increasing ER size before 
induction of protein production would correlate with an 
increased IgG yield in our system. We generated a yeast 
strain that, in addition to having a galactose-inducible 
cassette for encoding full-length human IgG inserted 
to its genome, had the OPI1-gene deleted. This strain, 
named here as Δopi1, was used throughout the screening 
along with the parental W303α-strain that had only the 
IgG expression cassette insertion, designated here as the 
wild-type (wt).
Growth of wt and Δopi1 strains was compared under 
non-inducing and inducing conditions for 40 h in com-
plex YPD and synthetic defined media. Under non-induc-
ing conditions, the Δopi1-mutant did not display any 
defects in growth, but reached a slightly lower optical cell 
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density (OD600) in complex media compared to the wild-
type, in stationary phase the OD600 being 1.762 for wt 
and 1.698 for Δopi1 yeast strain (P value< 0.001) (Fig. 1a). 
The same behavior was recorded in SD media with raf-
finose as the carbon source (Fig.  1b). However, during 
IgG expression, the maximal specific growth rate (µmax) 
was diminished and the µmax was 0.110 h−1 for wt and 
0.065 h−1 for Δopi1 cells in YPGal (Fig. 1a). The effect on 
growth rate was not as severe in SGal medium (Fig. 1b). 
In SGal the maximum growth rates were 0.280  h−1 for 
wt and 0.266 h−1 for Δopi1. However, in the production 
conditions represented in Fig.  1b, the lag-time of Δopi1 
was prolonged. Despite generally lower OD600 values in 
the cultures, the mean antibody titer of Δopi1 strain was 
up to three fold higher than that of the wild-type strain 
in the same conditions (Fig. 1c, Additional file 1). When 
the antibody titer was normalized to cell density, Δopi1 
performed up to 4.8-fold better than the wild-type in 
IgG-secretion when grown at 30 °C (Table 1, Additional 
file  1), clearly indicating that the characteristic increase 
in ER size by OPI1 deletion is beneficial for IgG produc-
tion. A similar positive effect of ER size manipulation has 
been reported for membrane protein production where 
the rerouting of metabolic fluxes from storage lipids to 
phospholipid biosynthesis led to an increase in ER mem-
brane and was accompanied by an improvement of mem-
brane protein accumulation due to the increased folding 
space [34]. In addition to increasing the ER functional 
space and affecting UPR-response, deletion of the OPI1-
gene might also be beneficial for protein production 
Fig. 1 Δopi1 deletion increases antibody production through increased ER size. a Growth of the two background strains was measured in complex 
(a) and synthetic media (b) at 30 °C. Used media are indicated in the graphs. Upper panels represent growth under non-inducing conditions, lower 
panels growth under inducing conditions. When antibody expression was not induced (a and b, upper panels), growth behavior of wild-type (wt) 
and Δopi1 strains was similar. While antibody expression was induced (a and b, lower panels), growth of Δopi1 mutant was reduced. c A notched 
box-plot presentation of all the measured antibody concentrations for the background strains shows that antibody secretion was considerably more 
efficient for Δopi1 in all temperatures. The number of measurement points used for each box is 82 or 84. d Fluorescence of GFP under an UPR-
responsive promoter was recorded in wt and Δopi1. The background corrected RFU-values remain much lower for Δopi1. Highest GFP fluorescence 
of wt was two times higher per OD compared to Δopi1
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because of the possible roles of its downstream effectors 
Ino4p and Ino2p in protein biosynthesis and transport 
[29], implying that Opi1p could also influence the protein 
secretion pathway through other, more complex effects.
Opi1p inactivation was shown to have a direct effect 
on alleviating conformational stress [15], so we inves-
tigated the magnitude of the unfolded protein response 
under antibody expressing conditions in Δopi1 and wt 
(Fig.  1d). We integrated an UPR-responsive cassette 
to both strains, which expresses an intracellular GFP-
signal upon induction of UPR [35]. Interestingly, in the 
beginning the increase of signal from the UPR-reporter 
occurred at the same rate in wt and Δopi1, but in the lat-
ter, signal increase persisted only during short time frame 
(Fig.  1d). As we used an intracellular reporter, growth 
might have an effect to the results. Nevertheless, if OD600 
values are taken into account, during the height of UPR-
induction levels in wt, the strain showed a much higher 
UPR-GFP signal than in Δopi1 (Fig. 1d, around 13 h). It 
is possible that the initial UPR-induction occurs at the 
same strength in wt and Δopi1, but the stress caused by 
the unfolded proteins is resolved faster in cells with a 
pre-enlarged ER. The UPR-signal persisted in wt until 
stationary phase of growth was reached, after which the 
reporter signal faded to a stationary level (Fig. 1d).
High‑throughput screening set‑up for optimizing IgG 
production in yeast
Adjusting the host organism for protein production is a 
complex process that requires optimization at several 
levels. The effects of single gene additions are hard to 
predict and are highly dependent on the client protein 
[5, 6]. To improve S. cerevisiae as an IgG factory, we set 
up a screening scheme summarized in Fig.  2. We cre-
ated a plasmid library of six factors that participate in 
protein folding, and to fine-tune their expression lev-
els, we selected five promoters of different strength to 
diversify our expression library. The promoters included 
the constitutive promoters PGPD and PTEF, the galactose-
inducible GAL1-promoter PGAL1, which activates the 
expression of the folding factor along with the induction 
of client protein expression, and also two UPR-inducible 
promoters from yeast genes KAR2 and PDI1, PKAR2 and 
PPDI1 respectively, which differ in their basal and induc-
ible expression levels [36]. Each promoter-gene com-
bination was tested both in wild-type and Δopi1 strains 
expressing human IgG. Based on the performances of the 
strains transformed with a single plasmid of the expres-
sion library, plasmids encoding proteins of different func-
tions were combined for another round of testing. In 
total, we tested 52 individual gene-promoter-strain com-
binations, and 67 strains with two different gene-contain-
ing plasmids.
For initial testing of single elements, plasmids encod-
ing the target genes were cotransformed with an empty 
plasmid with the complementary marker. This allowed 
us to use exactly the same media for initial testing and 
testing of combinations, as every strain contained both 
URA3 and LEU2 auxotrophic markers. The two back-
ground strain were transformed with two empty plas-
mids. In addition, this approach avoided bias in growth 
and metabolism, as different plasmid complementation 
has been shown to have an effect on various cellular pro-
cesses [37]. All screening experiments were conducted 
Table 1 List of strains with the highest specific antibody product yields
The data represent the mean value of the experiments conducted with 0.5 and 2 % galactose induction at 30 °C
a Relative frequency in the 95th percentile of Δopi1-strains
b Calculated with the nonparametric equivalent of t test, Wilcoxon signed rank test using the Δopi1-strain without added elements as the reference
c Averages of the fold-changes relative to wild-type
Strain  
number




P valueb Fold‑change  
relative to wild‑typec
154 CPR5-PGPD Δopi1 0.2027 0.2 0.000002 10.22
157 CPR5-PKAR2 Δopi1 0.1992 0.15 0.000159 10.15
155 CPR5-PGAL1 Δopi1 0.1579 0.1 0.000560 7.99
153 CPR5-PTEF Δopi1 0.1525 0.075 0.000036 7.66
156 CPR5-PPDI1 Δopi1 0.1424 0.05 0.007624 7.15
170 ERO1-PGAL1 Δopi1 0.1226 0.05 0.020502 6.13
212 SIL1-PGAL1 Δopi1 0.1223 0.05 0.021128 5.53
162 PDI1-PTEF Δopi1 0.1208 0.075 0.279237 6.09
206 LHS1-PGPD Δopi1 0.1163 0.05 0.299870 5.88
402 LHS1-PKAR2 + SIL1-PKAR2 Δopi1 0.1139 0 0.011316 5.73
83 None Δopi1 0.0886 0.075 4.47
73 None wt 0.0199 0 1
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entirely in 96-deep well format, inoculating a colony from 
solid media to one ml of liquid media in each well. As 
shown in Fig. 2, after the preculture the cells were divided 
into three replicate plates. Replica plates were grown at 
20, 25 and 30 °C. For induction of IgG expression, galac-
tose was added to final concentrations of 0.5 and 2  %. 
Each strain was cultivated three times, with inoculation 
of a different transformant and variation of the position 
in the culture plate to minimize plate position bias. The 
multiplexed conditions allowed us on one hand to gather 
better understanding about the link between a particular 
strain and antibody production and on the other hand 
on the effect of culture condition on IgG production. For 
analysis, OD600 was measured, and clarified supernatants 
were collected in duplicates from deep-well plates to 
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Fig. 2 Schematic representation of the screening set-up. We created a plasmid library by making different combinations of three DNA fragments: 
five different promoters, six coding regions for our selected proteins and two types of vector backbones, all containing the cyc1-terminator and 
either LEU2 or URA3 marker for recombinant selection. Plasmids from the library were transformed into the two background strains, wild-type and 
Δopi1, both having a single-copy of light and heavy chain genes under GAL1-promoter integrated into the HIS3 locus of their genome. Strains were 
inoculated from solid media to 1 ml of liquid media in 96-deep well plates, in which the strains were precultured for 21 h at 30 °C. The preculture 
was divided into three plates with fresh media and grown for 5.5 h at 30 °C before antibody expression was induced with 0.5 or 2 % galactose. 
Antibody was expressed for 24 h at the specified temperatures (20, 25 and 30 °C). Final OD600 of cultures was measured. Antibody titers were 
determined from cleared culture supernatants using two technical replicates with a high-throughput (HTP) ELISA on an automated liquid handling 
station. Each strain was analyzed in three independent biological replicates
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Antibody secretion increased with temperature and the 
effect of OPI1‑gene deletion was preserved in all 
transformant strains
Throughout all conditions screened, the two genetic 
backgrounds manifested as two distinguishable popula-
tions, as evidenced by differences in antibody produc-
tion (Fig.  3a), and growth (Fig.  3b). The corresponding 
distributions of specific product yields of the biological 
replicates are represented in Fig.  3c and individual rep-
licates expand up to 0.3  µg  ml−1 OD−1600. The antibody 
production increased with temperature (Fig.  3a) along 
with the OD-values (Fig.  3b), as specific product yield 
increased to a lesser extent (Fig.  3c). The Δopi1 strains 
reached generally higher antibody titers and lower OD600 
values manifesting in higher specific product yields, as 
also was shown for the background strains in Fig.  1. In 
the Δopi1 strains the effects of the added elements were 
mainly similar as in wild-type, but the relative changes 
in specific product yield were generally smaller when 
compared to the wt strain background (Additional files 
1, 2, 3). It has been reported that ER expansion in Δopi1 
strain does not affect the intrinsic cellular levels of ER 
chaperones, so the functional capacity of ER, defined as 
the amounts of chaperones and other folding assistants, 
would not increase according to the size [15]. This might 
indicate that a diluted ER environment is less prone for 
IgG aggregation and thus less sensitive to the effects of 
chaperone overexpression. On the other hand, the clear 
improvement in antibody secretion achieved with OPI1-
gene deletion was preserved also during chaperone over-
expression (Fig. 3c; Additional files 1, 3).
In total, we identified 49 cases where a more than 50 % 
increase in antibody titers was measured and 71 cases 
where a more than 1.5-fold increase of the specific product 
yield was recorded when compared to the respective strain 
background. One question that arose from these experi-
ments was whether the higher antibody titers were due 
to the increased growth or to increased specific product 
yield. To estimate this, we fitted a linear model to all data 
points (Fig.  3d). The mean values of OD600 and antibody 
titer from each strain were normalized to the respective 
background strain values to fit all the conditions to the 
same value space. A linear regression plane was fitted to 
the data points to model the dependency of the normalized 
antibody titer on the normalized specific product yield and 
normalized OD600. The multiple R-squared value for the 
model was 0.8896, indicating that there was a significant 
linear dependency. The model estimated the coefficients 
to be 0.6114 for OD600 and 0.8573 for the specific product 
yield, indicating that improved specific product yield has 
a bigger positive effect on antibody titer than an increase 
in OD600. The linear model implies that the effects of the 
elements on secreted antibody amounts are more depend-
ent on changes in cellular productivity than on effects in 
growth. The calculated P values for the model fit measured 
by F test and also for the coefficients are ≪ 0.001 represent-
ing a reliable statistical significance for the linear model.
Both OD600 and antibody titer values increased stead-
ily with the temperature (Fig.  3a, b), and the absolute 
differences between different strains were most promi-
nent at 30  °C. The differences manifested themselves by 
a wider range of antibody titers at 30  °C (Fig.  3a) and 
the increasing variance in the strain antibody titer indi-
cates (Additional files 1, 3), that the strain phenotypes 
diverge more with increasing temperature and thus are 
more clearly visible at 30 °C. The induction strength also 
had effect on the IgG secretion, mainly secreting higher 
amounts at 0.5  % galactose (at 30  °C, mean antibody 
concentration was 0.0254  µg  ml−1 for 0.5  % galactose 
and 0.0207 µg ml−1 for 2 % galactose for all strains with 
wild-type background). When antibody concentration 
was normalized to OD600, the specific product yield did 
not differ significantly for the two induction conditions 
(respective values are 0.0210 and 0.0201  µg  ml−1OD−1600 
for 0.5 and 2.0  % galactose, respectively). Since the two 
induction strengths resulted in similar outcomes, we 
focus on 0.5  % galactose in our analysis as it yielded 
higher concentrations of secreted IgG. The results from 
all strains tested along with the two background strains 
are reported in Additional files 1, 3.
(See figure on next page.) 
Fig. 3 Population analysis of total screening data. Even with added genes, the two background strains perform differently as determined with 
antibody titer (a) and optical density (b), forming two populations of measurement values. Δopi1 (dashed red line) had generally higher antibody 
concentrations (a) and lower OD600-values (b) than the wild-type (black solid line) at all temperatures tested. Distribution of the specific product 
yields calculated separately for each sample and replicate are shown in (c). The distribution of values is shown as density plots, where the area 
under the line is equal to 1 (total probability of a measurement value being under the line) and the y-axis is proportional to relative frequency. The 
range of the measured values is given in the x-axis. Each condition included the analysis of 113 different strains and the number of measurement 
points in each curve is between 798 and 824 in (a) and 399–412 in (b) and (c). The mean values for each strain were normalized to the respective 
background strain and plotted together to represent all the measured values (d). A linear regression plane (dashed lines) was fitted to the data 
points to model the dependency of antibody titer on combined effects of OD600 and normalized specific product yield. Multiple R-squared was 
equal to 0.8896 indicating that a linear dependency was found. The estimated coefficient of fold-change was higher than that for the normalized 
OD600, meaning that a change in specific product yield had a higher impact on the antibody titer values. Colors are added only to aid the visual 
clarity in (d)
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The peptidyl‑prolyl isomerase CPR5, a novel player 
to increase antibody production
Antibody titers/specific product yields varied accord-
ing to chaperone or helper protein, but also according 
to the promoter used. Figure 4a presents a heatmap that 
displays a summary of the fold changes in specific prod-
uct yield that the added elements induced in the wild-
type strain and Fig. 4b is a similar heatmap for the Δopi1 
strain, both at 30 °C with 0.5 % galactose induction. For 
comparison, heatmaps from 2 % galactose induction are 
included in Additional file  2, displaying that in general, 
the effects of the elements are similar in different strain 
backgrounds and conditions.
Standing out as the most beneficial gene for increas-
ing antibody titers, CPR5 expression improved the spe-
cific product yield 1.65–3.25-fold depending on the 
promoter and condition used. Cpr5p is an ER localized 
PPIase involved in the rearrangement of peptidyl-prolyl 
Fig. 4 Effects of single folding factor overexpression on antibody secretion. A heatmap representing the change in specific product yield of each 
strain relative to the strain background. The colors and numbers in each cells represent the fold-change that the specific promoter gene combina-
tion had on the specific product yield. CPR5 overexpression yielded the most beneficial impact. The values are for wild-type yeast strains grown 
at 30 °C and for 0.5 % galactose induction (a) and Δopi1 strains in the same conditions (b). c Temperature and type of promoter affect the effect 
of CPR5 on the specific product yield in wild-type. UPR-controlled promoters, PKAR2 and PPDI1, show an increase in the positive impact on antibody 
secretion with increasing temperature, as displayed by the trend line. The specific product yield of wild-type is included as comparison. The values 
are from measurements with 0.5 % galactose induction. d Promoter strengths measured by qPCR of CPR5 mRNA levels at 2 and 10 h after induction 
with 2 % galactose at 30 °C. Relative normalized expression is calculated as setting the CPR5 mRNA levels from wt as control. The promoters show 
different characteristics, as the UPR-inducible promoters follow the wt levels and PGAL1, PGPD and PTEF have higher initial mRNA amount
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bonds in unfolded proteins [38]. PPIases have often been 
neglected in studies of recombinant protein folding and 
production, although specifically with full-length anti-
bodies, the isomerization of certain proline residues has 
been determined to be the rate-limiting step in antibody 
folding in some cases [21, 39–41]. Feige et  al. reported 
also that immunoglobulin domain folding in vitro could 
be enhanced by addition of the cytoplasmic yeast PPIase 
Cpr6p [41]. In our study, the best results of CPR5 expres-
sion were achieved with the UPR-induced promoter 
PKAR2, with which the strains showed to be secreting the 
most IgG at 30 °C (Fig. 4b). As seen in Fig. 4c, the effects 
of the individual elements were not equal at the different 
temperatures, as also can be stated for other elements, 
but generally the induced changes in specific product 
yield were to the same direction (Additional files 1, 3).
The nucleotide exchange factors Sil1p and Lhs1p are 
regulating Kar2p activity by maintaining its ATPase cycle 
through ATP hydrolysis and subsequent ADP release [42, 
43]. In Fig. 4a, b we show that using the Kar2p co-chap-
erones was successful in improving antibody titers, Sil1p 
showed a clear positive effect (up to 1.5-fold higher secre-
tion), especially in wt background (Fig.  4a), and Lhs1p 
induced a modest increase in titers. These co-chaperones 
have been used before to improve the overexpression of 
human transferrin and recombinant human albumin, 
although with slightly lower fold-changes [44].
Although overexpression of Pdi1p and Kar2p have been 
shown to improve the secretion of single-chain antibod-
ies in S. cerevisiae [26–28], in our analysis both of these 
proteins displayed mostly negative effects on antibody 
secretion at all induction levels and expression conditions 
(Fig.  4, Additional files 1, 2). The considerable reduc-
tion in IgG secretion when overexpressing PDI1 under 
strong promoters (PGAL1, PGPD) was rather surprising, as 
its overexpression has shown to be increasing titers for 
various heterologous proteins [45–47]. Besides a pos-
sible disruption of the cellular redox balance by a too 
high concentration of Pdi1p [48], there has also been evi-
dence that the protein facilitates the ERAD of some sub-
strates [49]. The importance of oxidative balance can be 
also seen from the effects of Ero1p, another redox-active 
protein, as the secretion of IgG shows to vary greatly 
depending on the expression level of ERO1 (Fig.  4a, b; 
Additional file 2).
Under normal conditions, Kar2p associates with 
Ire1p in the ER and so represses UPR-induction. When 
unfolded proteins are present, Kar2p releases from Ire1p 
and binds them, after that Ire1p can dimerize and induce 
the UPR [8, 50]. It has been shown that overexpression 
of Kar2p attenuates Ire1p activation [51] and this makes 
it possible that the overexpression leads to decreased 
IgG secretion through an inhibition of the UPR and thus 
accumulation of the unfolded IgG in the ER. Our data 
above showed that it is more reasonable to concentrate 
on regulating the activity of Kar2p by the expression of 
its co-chaperones Sil1p and Lhs1p, as improved Kar2p 
cycling might benefit the folding process. It has been esti-
mated that Kar2p is by far the most abundant protein of 
this trio, with around 300,000 molecules per cell, whereas 
of Sil1p and Lhs1p around 2400 and 140 molecules are 
present in the ER [52]. This indicates that increasing the 
abundance of the regulators can have great effects on 
Kar2p function. For the production of IgG, this is further 
supported by data that the Kar2p mammalian homolog 
BiP does not cycle away efficiently from both unassem-
bled heavy and light chain [53, 54], which might stall pro-
tein folding at high Kar2p levels in the ER.
To estimate the extent of chaperone overexpression, 
we measured the mRNA levels of CPR5 with qPCR from 
wt strains overexpressing CPR5 under control of differ-
ent promoters 2 and 10 h after induction (Fig. 4d). Com-
pared to the wt strain harboring only the native gene 
copy under control of the endogenous promoter, CPR5 
expression under control of GAL1, GPD and TEF pro-
moters resulted in a very high initial induction of CPR5 
expression, especially under GAL1-promoter (Fig.  4d). 
Ten hours after induction, CPR5 mRNA abundance was 
comparable in all strains harboring an overexpression 
plasmid. Interestingly, expression of CPR5 under con-
trol of PPDI1 or PKAR2 was only slightly enhanced at both 
time points compared to the control (Fig.  4d). The data 
indicates that using UPR-responsive promoters enables 
a moderate overexpression that stays more consistent 
throughout the production process. The UPR-induced 
promoters proved to be promising and should be consid-
ered when chaperones are overexpressed to enhance het-
erologous protein production.
Combining different genes provided little additional 
benefit to IgG production
After evaluating all the individual elements and deter-
mining the best promoter for each gene, we started 
screening for gene combinations that would further 
improve IgG secretion. For selecting the combinations, a 
rational approach was applied based on the known func-
tionalities and interactions of the genes aiming to achieve 
complementary actions. Optimal expression levels of the 
gene pairs are crucial but most likely hard to predict, so 
for the selected pairs we tested a few promoter options. 
All the selected pairs along with all the measurement 
results from the screening process are listed in detail in 
Additional file 3, while Additional file 4 provides a sum-
marized overview of the mean fold-changes. The meas-
urements from the second round are included in Fig. 3, 
thus the general trends discussed above apply to double 
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gene combinations as well. Again we focus mainly on the 
results of the experiments performed at 30 °C, as in these 
conditions the highest antibody titers were obtained 
and thus the conditions are most interesting for further 
applications.
We did not discover any gene pairs with beneficial syn-
ergistic or combinatorial effects. When improving, the 
fold-changes in overexpression of two elements were 
less than achieved with just one element. For example, 
CPR5 expressed alone induced a significant increase in 
IgG secretion, but combining the overexpression with 
other elements, for example LHS1 or SIL1, resulted in no 
more than 2.3-fold increase at 30 °C (biggest fold-change 
with CPR5-PKAR2/LHS1-PKAR2 combination, see Addi-
tional file 3), lower than the observed three-fold for CPR5 
alone. As shown in Fig. 5, negative synergistic effects did 
also occur, often with Kar2p overexpression. The poor 
performance of two element combinations is reflected 
by their high occurrence in the lowest, 5th percentile of 
measurement points (Additional file 5). Targeting of mul-
tiple proteins to the ER might be too demanding for the 
cell, resulting in protein production stress and high occu-
pancy in the translation/translocation machinery thus 
leading to inefficient secretion. Also, with the overex-
pression of more folding factors, there is a higher chance 
to disturb other cellular processes, which might have an 
indirect combinatorial negative effect on antibody titers. 
However, overall we did not observe any clear changes in 
growth when compared to the strains that express only a 
single element, indicating again that the secretion levels 
are more dependent on the ability of cells to process IgG 
and not on changes in OD-values as described in Fig. 3d.
Co-overexpressing Lhs1p and Sil1p, both under PKAR2, 
increased the specific product yield by up to 1.5-fold 
(Fig.  5, Additional files 3, 4). As Lhs1p and Sil1p con-
trol Kar2p activity by determining the rate of the ATP-
phosphorylation cycle [42], overexpressing both of them 
might be important to adjust the speed of the Kar2p 
binding cycle to the increased demand for substrate fold-
ing. Although LHS1-PKAR2/SIL1-PKAR2 was one of the 
best combinations in enhancing the specific product 
yield, an effect of the same magnitude was achieved by 
overexpressing Sil1p alone. This indicates that Sil1p is the 
main protein providing the ADP release step in Kar2p 
cycling. Interestingly, as with CPR5 overexpression, the 
higher antibody titers of the LHS1-PKAR2/SIL1-PKAR2 
were accompanied by a slightly lower OD-values (Addi-
tional files 3, 4). There might be significant competition 
for cellular resources between high level protein pro-
duction and growth [55–57], which might also explain 
why addition of multiple folding factors did not produce 
higher antibody titers.
The strain with highest specific product yield, 
Δopi1 + CPR5‑PGPD, has 10‑fold higher specific IgG yields 
than the wild‑type
Overexpression of Cpr5p under any promoter proved to 
yield the highest amounts of secreted IgG per cell. When 
combined with the Δopi1-mutation, the specific prod-
uct yield could be increased up to 10.2-fold compared 
Fig. 5 Performance of two-gene combinations compared to the overexpression of only one of the genes. Bar plots showing the relative specific 
product yield for selected gene combinations and the respective single genes in wild-type (a) and Δopi1 yeast strains (b). LHS1- PGAL1 and KAR2–
PGAL1 seem to have synergistic negative effect since their combination decreases the specific product yield below the level of the combined or 
individual effects. LHS1–PKAR2 with SIL1–PKAR2 had the most positive effect on specific product yield out of all the double gene combinations, but 
the increase was at the same level as achieved by insertion of SIL1- PKAR2 alone. Although the effects of the added genes are similar for Δopi1 (b), 
the effects are higher in magnitude in wild-type strain background (a). Error bars represent the standard deviation and the selected values were 
obtained with 0.5 % galactose induction at 30 °C. Specific product yield is normalized to the mean specific product yield of the respective back-
ground strain grown in the same conditions
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to the wild-type in the same conditions. The ten strains 
with highest mean specific product yields are listed in 
Table  1. Based solely on 0.5  % induction, as shown in 
Fig.  4b, CPR5-PKAR2 provided most enhancement with 
the Δopi1-strain. However, when evaluating a combi-
nation of the 0.5 and 2  % conditions, overexpression 
of CPR5 under the GPD-promoter provided the high-
est mean improvement in specific product yield. The 
Δopi1 + CPR5-PGPD strain yielded specific antibody titers 
of around 200  ng  ml−1 OD−1600, corresponding to a final 
antibody concentration of 126  µg  l−1 with 0.5  % galac-
tose induction which is five times more than with the 
wild-type strain (Table 1; Additional file 1). Although our 
yeast system was significantly improved, the final anti-
body concentrations we achieved remained very modest. 
Many mammalian systems and cell lines, such as Chinese 
hamster ovary (CHO), HEK293, and a new cell line called 
F2N78 [58–60], achieve titers in the scale of hundreds of 
milligrams per liter after unprecedented cell line selec-
tion and engineering efforts. Our titers are several mag-
nitudes lower, but comparing different systems is not 
straightforward in terms of parameters such as final con-
centration. Performance of different platforms in recom-
binant protein production was studied by Maccani et al. 
[61], where the authors show that based on the space–
time yield of a single chain antibody, CHO cells perform 
only 10 times better than the yeast Pichia pastoris. Our 
approach of expressing full-length antibodies differs from 
the common use of single chain antibodies as the client 
protein, so it is expected for our variant to display lower 
yields due to increased complexity. A fivefold increase in 
space–time yield was obtained here by optimizing just 
one aspect (folding and ER environment). There are still 
many approaches left for improving strain performance 
and yields including many genetic targets and selection 
of a strain background more suitable for protein produc-
tion. Together with process optimization, final antibody 
concentration could reach economically feasible levels in 
the future.
In Table 1, we display the mean values for the specific 
product yield at 30  °C for the two induction strengths, 
as combining these two conditions gives a more reli-
able estimation for the quantitative change for each 
element. Within some strains, we observed a high vari-
ance between measurements, especially at high antibody 
titers, probably resulting from a combined effect of dif-
ferences in cellular state and unavoidable technical inac-
curacy (high SD values in Additional files 1 and 4, also 
Fig. 5). To validate the results of the most different phe-
notypes, we conducted frequency analysis to determine 
which strains were enriched among the lowest (5th per-
centile) and highest (95th percentile) five percent of 
all measured specific product yields, divided by strain 
background and temperature (Additional file  5). Repre-
senting some outlier measurements, a few instances from 
the wild-type background strain occurred in both per-
centiles, since at least one replicate was grown on each 
deep-well plate to assess the overall success of the plate 
culture. Many of the same elements occur in the same 
percentiles in both background strains and different tem-
peratures, indicating that the changes from the elements 
are generally consistent throughout the assay. Another 
measure of the reliability of the fold-change of the added 
elements is the low P-value (as determined by Wilcoxon 
signed rank test) calculated for many of the strains when 
compared to the respective strain background. Combi-
nation of low P value and high frequency displays a sta-
tistically significant fold change and very reliable results 
for the five best strains with overexpressed Cpr5p, and to 
most other distinctive phenotypes that we encountered 
(Table 1, Additional file 5).
Analysis of cellular IgG clearance from selected strains
When using cellular engineering to improve heterologous 
protein production, it is also useful to gain understand-
ing of the underlying changes in strains with interesting 
secretion phenotypes. To gain more insight in how some 
of the overexpressed folding factors influence the pro-
gression of the antibody through the cell, we selected five 
strains for use in a cellular clearance assay as described 
in De Ruijter and Frey [12]. The strains were as follows: 
the two genetic strain backgrounds; wt and Δopi1, the 
highest producers from both backgrounds; wt with the 
CPR5-PKAR2 plasmid, and Δopi1 with the CPR5-PGPD 
plasmid, and finally one of the strains with a negatively 
affecting gene combination: Δopi1 with the KAR2-PGAL1 
and the LHS1-PGAL1 plasmids. In short, cultures in the 
log-phase were induced with 2 % galactose for 4 h, after 
which 2 % glucose was added to inhibit expression from 
the GAL1 promoter. After 0, 2, 4 and 6  h cell extracts 
were prepared, which were analyzed for heavy (HC) and 
light chain (LC) content using SDS-PAGE and Western 
blot. For quantification of IgG signals, the corresponding 
anti-tubulin signal was used to correct for differences in 
protein loading. The resulting Western blots are shown in 
Fig. 6a, c.
With the mock treatment, all strains kept producing 
IgG for the duration of the assay, as seen by a continu-
ously present signal for the heavy and light chain blots 
(Control columns of Fig. 6a, c). When IgG expression was 
repressed by addition of glucose, intracellular IgG levels 
decreased during the assay and no HC was detected in 
the samples after 6 h. However, most of the LC samples 
showed still residual signals at the last time point. Clear-
ance curves were calculated for heavy and light chain that 
were corrected for loading with the quantified tubulin 
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signals from the glucose treated samples. The relative 
amount of signal was calculated with respect to the zero 
time point and the resulting clearance curves are shown 
in Fig.  7, which shows that HC and LC follow different 
clearance patterns from each other and between strains. 
This is not unexpected, as the light chain can be secreted 
separately, as opposed to the heavy chain that needs the 
light chain to correctly fold into the full IgG molecule in 
order to be secreted [21].
For a relative comparison of the intracellular load of 
HC and LC at the start of the glucose treatment, the sam-
ples from zero hours for each strains were compared for 
HC and LC signal intensities in Fig.  6b, d respectively. 
A notable difference was the increased intracellular HC 
concentration in the Δopi1 derived strains compared 
with the wild-type derived strains, which was accompa-
nied with a slightly slower clearance. The Δopi1 strain 
had an around 75  % higher initial HC load when com-
pared with the wt strain and the best producing Δopi1 
overexpressing Cpr5p strain had more than two times 
higher HC load compared to wt Cpr5p overexpressing 
strain. Overall, a trend towards a higher intracellular HC 
load was detected in the Δopi1 background. It has been 
shown for CHO cells that a high cellular content of HC 
is a molecular marker that characterizes efficient produc-
ing clones [62]. The same study showed also a lower cor-
relation between LC content and productivity, while it 
has been shown that LC content has a strong correlation 
with strain productivity in heterohybridoma cells [63]. 
Although the intracellular LC levels in the analyzed best 
producing Δopi1 strains are quite similar to wt (Fig. 6d), 
the clearance of LC is slower in these strains (Fig.  7b), 
indicating that it might be favorable to have a pool of LC 
available for full IgG assembly.
The Δopi1 + KAR2-PGAL1 + LHS1-PGAL1 strain, which 
was showing a decreased IgG secretion, was included 
in this assay and showed a different pattern from the 
other strains. Even with a relatively low initial HC 
(after correction for loading) and LC load compared 
with the background Δopi1 strain, the clearance of HC 
was decreased and the clearance of LC was increased 
(Fig.  7a, b respectively). These results from our 
Fig. 6 Analysis of cellular IgG clearance using Western blot. a Antibody expression in exponentially growing cultures of different strains (wt, Δopi1, 
Δopi1 + CPR5-PKAR2, wt + CPR5-PGPD and Δopi1 + KAR2-PGAL1 + LHS1-PGAL1) was induced with galactose for 4 h, after which IgG expression was 
repressed by addition of glucose, in control experiments, the induction was continued. Heavy chain (HC) clearance was followed for 0, 2, 4 and 6 h. 
After incubations, cell extracts were prepared from the cultures and analyzed using SDS-PAGE and Western blot. A representative blot for tubulin, 
used as loading control is shown. b Samples from time point zero from all strains were loaded on one gel, and the measured HC signals were visual-
ized using Western blot, their respective tubulin signals are shown as loading controls. c Same as in (a), but samples were reprobed to visualize the 
light chain (LC) signals. d Same as in (b), but samples were reprobed to visualize the LC signals
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clearance analysis indicate that a constant availability of 
LC in the cells might be beneficial for an efficient secre-
tion of fully folded IgG molecules. Folding speed might 
be crucial to improve secretion, but addition of chap-
erones might have unpredictable effects to the balance 
between LC and HC, as their function might be frag-
ment specific. Thus, such high-throughput screening 
methods as presented here are giving insights towards 
what is needed for effective engineering of multisubunit 
protein folding.
Conclusions
We show here that inducing an ER expansion in the 
yeast S. cerevisiae can improve the secretion capacity 
of full-length antibodies up to fourfold. In addition, six 
genes (PDI1, ERO1, KAR2, LSH1, SIL1, and CPR5) were 
expressed in order to improve the folding environment 
in the ER. Improving the folding environment by overex-
pression of ER folding factors is not always achieved in 
a predictable manner. However, in general the effects of 
cell engineering on IgG titers are manifesting themselves 
most clearly at higher cultivation temperatures. Our data 
demonstrates that expression levels are crucial, especially 
when combining different factors within one strain, as 
these showed no synergistic effects in antibody titers. 
However, by using UPR controlled promoters, the fold-
ing environment dynamically responds to changes in ER 
load and expression levels are adjusted only when neces-
sary, and this could provide a better approach for strain 
engineering.
The PPIase Cpr5p was shown to enhance antibody 
secretion the most. Combined with the ER expansion 
by Δopi1, the improved specific antibody yield of over 
10-fold higher compared to wild-type was achieved in 
small scale conditions. Although the strain reached a 
lower cell density, even the absolute antibody titer was 
over fivefold higher than the wild-type strain. This makes 
the Δopi1  +  CPR5-PGPD strain a very interesting can-
didate for further studies, as the combination of strain 
engineering with process optimization might develop 
S. cerevisiae systems into a viable alternative for current 
antibody producing platforms.
Methods
All used FastDigest—restriction enzymes Phusion High-
Fidelity DNA Polymerase were obtained from Thermo 
Fisher Scientific (Vantaa, Finland). All media compo-
nents and reagents were obtained from Sigma-Aldrich 
(Helsinki, Finland), unless stated otherwise. Yeast nitro-
gen base without amino acids (YNB) was obtained from 
BD (Vantaa, Finland). All sequences of oligonucleotides 
are listed in Additional file 6.
Yeast strains
All S. cerevisiae yeast strains were derived from the 
parental strains W303α (ATCC® 208353™). Two types 
of stable yeast strains were used in this study: W303α 
and W303α∆opi1, both with IgG1-producing genes 
(heavy and light chains encoding the monoclonal anti-
body C2B8) integrated to HIS3-site of the genome. 
These IgG-producing W303α and W303α∆opi1 back-
ground strains are referred to in the manuscript as wt 
and ∆opi1, respectively. The W303α∆opi1 deletion strain 
was created as described in Hegemann and Heick [64]. A 
Fig. 7 Quantitative analysis of IgG clearance. Signals from the blots (HC and LC) in Fig. 6a and c were quantified and normalized with their cor-
responding tubulin signals and used to plot their clearance curves in (a) and (b), respectively. The data represents the average of two or three blots 
normalized for loading differences using an anti-tubulin blot. There is a clear variation between HC and LC clearance for all strains and also between 
the strains in both of the plots. The data gives a general indication that a constant pool of available LC might be beneficial for efficient IgG folding 
and secretion
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loxP–kanMX–loxP disruption module targeting the OPI1 
gene was generated from pUG6 [65] with PCR, using oli-
gonucleotides 3 and 4. The cassette was transformed to 
W303α and positive transformants were selected using 
YPD-agar media, supplemented with 200  µg/mL G418 
(Sigma-Aldrich, Helsinki, Finland). Positive knockouts 
were verified with colony-PCR using oligonucleotides 
5 and 6. Cre-recombinase was expressed from plasmid 
pSH47 [65] to remove the gene disruption cassette from 
the genome following the protocol presented in Hege-
mann and Heick [64].
The plasmid for the IgG gene integration was achieved 
as follows: a fragment from pEK5 plasmid [12], con-
taining genes for heavy and light chain each under 
GAL1-promoter, was amplified with PCR by using the oli-
gonucleotides 1 and 2. These oligonucleotides contained 
complementary 5′ ends to the pRS303N-plasmid [66]. 
pRS303N was linearized with Ecl136II and the amplified 
DNA fragmented was joined with the vector as described 
in Koskela and Frey [67]. The 6.8 kb DraIII and Bsp119I 
fragment of the resulting pEK12 plasmid was transformed 
into W303α and W303α∆opi1 strains with the lithium 
acetate method. Selection of transformed colonies was 
achieved by adding 200 µg/mL LEXSY NTC (Jena Biosci-
ence, Jena, Germany) to the growth medium. IgG expres-
sion of the colonies was confirmed with ELISA.
Yeast cultures for growth curves
For recording of growth curves, cultures of exponen-
tially growing cells were diluted to OD600 of 0.02 in 
YPD and YPGal (1 % yeast extract, 2 % peptone, and 2 % 
glucose or galactose, respectively) and liquid synthetic 
drop out (SD) medium containing 2  % raffinose or 2  % 
raffinose supplemented with 2  % galactose (SGal). One 
hundred microliters of these cultures were grown in a 
round-bottom microtiter plate, with continuous orbital 
shaking (425 rpm, 3 mm) at 30 °C in an Eon Microplate 
Spectrophotometer (BioTek, Winooski, USA). OD600 
measurements were taken every 15  min for 40  h. The 
growth curves were analyzed with R-package grofit and 
the characteristic growth parameters were extracted 
from the spline fit, a data fitting function provided by 
the grofit-package [68]. The experiment was conducted 
with seven or eight culture replicates and the statistical 
significance of the difference between the two strains 
was determined with Wilcoxon signed rank test (as 
described below).
Analysis of the UPR induction
The UPR-responsive cassette encoding GFP from plasmid 
pDEP017 [35] was linearized with EcoRV and integrated 
into the TRP1-locus of Δopi1 and wt production strains. 
The functionality of the integrated cassette was con-
firmed by induction of UPR through addition of 5  mM 
DTT. For UPR measurements, the strains were grown 
over night at 30 °C, 250 rpm and diluted to OD600 = 0.1 
into 96-well plates using SGal media. Cultures were 
grown with continuous orbital shaking (425 rpm, 3 mm) 
at 30  °C using a Cytation 3 Microplate Spectrophotom-
eter (BioTek, Winooski, USA), OD600 and GFP-fluores-
cence measurements were taken every 15 min for 24 h.
Cloning of overexpression plasmids
The genomic DNAs of the selected genes were cloned into 
yeast shuttle vectors pRS415 and pRS416 containing TEF, 
GPD and GAL1 promoters [69, 70]. The pRS41X vectors 
were modified to include the UPR-controlled promoters 
from S. cerevisiae genes PDI1 and KAR2. For exchanging 
of the promoter, fragments 355 bp upstream of PDI1 and 
281 bp upstream of KAR2 were first amplified with PCR 
from yeast genomic DNA, using oligonucleotides 7, 8, 9 
and 10, respectively. Next, to generate complementary 
sequences overlapping with the vector backbone ends for 
insertion of these fragments with exonuclease and liga-
tion-independent cloning (ELIC) [67], a second round of 
PCR was performed on these products with oligonucleo-
tides 11, 12, 13 and 14, respectively. These fragments were 
inserted into  SacI/XbaI linearized plasmids pRS415 and 
pRS416 to create the PPDI1 and PKAR2 empty vectors with 
the different auxotrophic selection markers.
The plasmids expressing PDI1, ERO1, CPR5 and 
KAR2 under TEF, GPD and GAL1 promoters, were con-
structed using PCR on S. cerevisiae genomic DNA with 
their respective oligonucleotide pairs (oligonucleotides 
15–22). The PCR amplified fragments were inserted into 
the SpeI XhoI sites of the pRS415 and pRS416 vectors, 
using standard ligation cloning.
The PDI1, ERO1, CPR5 and KAR2 plasmids with PKAR2 
and PPDI1 promoters were constructed by using ELIC. 
A PCR reaction was made with oligo 36 (3′ end) and the 
oligo corresponding with the inserted gene from oligonu-
cleotides 23–25 (5′ end), and using the previously created 
TEF-promoter-gene plasmids as template. The newly gen-
erated fragments were used for a second round of PCR to 
add the complementary sequences for the vectors to the 
inserts, using oligo 36 (3′ end) with oligo 34 or 35 (5′ end). 
These final PCR products were inserted into the SpeI/XbaI 
and XhoI sites of the pRS-shuttle vectors using ELIC.
To construct all the LHS1 and SIL1 expression plas-
mids, oligonucleotides 26&27 and 28&29, respectively, 
were used to amplify the DNA of LHS1 and SIL1 from 
S. cerevisiae genomic DNA. In a second PCR round, the 
complementary sequences overlapping with the vec-
tors were added to the inserts, using oligo 30 (3′ end) 
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with either oligo 31, 32, 33, 34, or 35 (5′ end). These PCR 
products were inserted into the SpeI/XhoI and XbaI/XhoI 
fragments of the pRS-shuttle vectors using ELIC cloning.
Empty marker plasmids for use as a control were the 
recirculated forms of pRS41X-vectors after SacI and 
NaeI digestion. A list of all plasmids used can be found in 
Additional file 7.
Yeast expression cultures
Screening of the yeast strains was conducted with 96- 
deep well plates in a culture volume of 1 ml per well. A 
colony from each strain was inoculated to SD medium 
lacking leucine and uracil, containing 2 % raffinose. As a 
control, the IgG expressing wild-type and ∆opi1 strains 
with empty plasmids were included in every plate. Pre-
cultures were grown at 30 °C, 250 rpm for 21 h. The cul-
ture was diluted 1:4 with fresh SD media, containing 2 % 
raffinose, supplemented with 0.05 mg/ml BSA. The cul-
tures for IgG expression were grown at 30  °C, 250 rpm) 
for 5.5 h before protein expression was induced by adding 
0.5 or 2  % galactose. Protein expression was continued 
for 24 h at 20, 25 or 30  °C, 250  rpm. Culture deep-well 
plates were centrifuged at 2250 rcf, 10  min to clarify 
the supernatant samples. Cell-free supernatant was 
divided into two 300 µl samples adjusted to 1x PBT (PBS 
(135 mM NaCl, 2.5 mM KCl, 10 mM Na2HPO4, 1.75 mM 
KH2PO4) + 0.5 % Tween-20) and stored at −20 °C until 
analysis, done within 2  days. Each sample was meas-
ured with three independent biological replicates, each 
with two technical replicates in ELISA. OD600 was meas-
ured before dilution and from final samples with an Eon 
Microplate Spectrophotometer (BioTek, Winooski, USA).
Enzyme‑linked immunosorbent assay (ELISA) for antibody 
titer measurement
The ELISA assay was realized on MICROLAB STAR 
Liquid Handling workstation (Hamilton, Bonaduz, Swit-
zerland) extended with ELx405 Select deep well washer 
(BioTek Winooski, USA) and Synergy 2 plate reader 
(BioTek Winooski, USA). Antibody titer was determined 
as described in de Ruijter and Frey [12].
Data processing and statistical analysis
All measurement data was collected, combined and 
moved into R software environment and processed and 
visualized with the packages therein. Outliers resulting 
from measurement errors were manually removed after 
visual analysis of replicate measurements. The perfor-
mance of the strains were validated with frequency analy-
sis, where the count and relative frequency inside the 
percentile was determined by strain and for individual 
measurement points. The cut-off values for 5th and 95th 
percentiles were determined with quantile() –function. P 
values are from independent two-group and two-tailed 
Wilcoxon signed rank test (performed with wilcox.test() 
–function), where the measurement values of the respec-
tive strain background standard served as the reference. 
The linear regression plane was fitted to the data with the 
function lm() where dependency of normalized antibody 
titers on the joint effects of normalized OD600 and nor-
malized specific product yield was modeled.
Real‑time PCR
Cultivation was conducted as described for screening 
assay: Selected strains were inoculated to 1 ml media in 
96-deep well plates grown once to saturation and diluted 
and grown for 5.5 h. After induction with 2 % galactose, 
the cultures were grown for 2 or 10 h at 30 °C. 1.5 OD600 
of cells was collected for mRNA isolation. IgG expression 
was confirmed from supernatants with ELISA. mRNA 
was isolated from cell pellets with RNeasy® Mini Kit 
(Qiagen), and approximately 10 µg of mRNA was treated 
with TURBO DNA-free™ DNAse (Ambion® RNA by 
Life Technologies). After DNAse inactivation, mRNA 
was converted to cDNA with AffinityScript QPCR cDNA 
synthesis kit (Agilent Technologies, USA), according to 
manufacturer’s protocol. qPCR was performed with a 
CFXConnect thermocycler (Bio-Rad, USA) on 100  ng 
of cDNA using commercial PrimePCR™ SYBR® Green 
Assay CPR5, Yeast primers (qSceCED0004208, Bio-Rad, 
USA), while ACT1 levels were measured as a loading 
reference with primers 37 and 38. Maxima SYBR green/
fluorescin qPCR Master Mix (Thermo Scientific, USA) 
was used as reagent according to manufacturer’s proto-
col. Results from three technical replicates were analyzed 
with the Bio-Rad CFX Manager 3.0 software, using ACT1 
as loading control and with normalization to the CPR5 
signal from the wt sample.
Cellular clearance assay
The cellular clearance assays was performed as described 
in De Ruijter and Frey [12]. Using anti-human IgG (Fc 
specific)-peroxidase labelled antibody produced in goat 
for heavy chain detection and anti-Human kappa light 
chains (Bound and Free)-peroxidase antibody produced 
in goat for light chain detection. Rabbit anti-tubulin anti-
body [EPR13799] (Abcam, Cambridge, UK) and goat 
anti-rabbit IgG (Fc specific)-peroxidase labelled were 
used for tubulin detection. Signal detection was done 
with the Supersignal™ West Pico Chemiluminescent 
Substrate (Thermo Fisher Scientific, Vantaa, Finland), fol-
lowing the manufacturer’s instructions.
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